Clinical diagnosis of all MPS I subtypes is confirmed by elevated levels of dermatan and heparan sulfate in the urine and deficiency of IDUA enzyme activity in leukocytes or fibroblasts [Neufeld and Muenzer, 2001]. This evidence concerns the gene IDUA and Scheie syndrome.